OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RNA m6A methylation regulators in liver cancer
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors
I.H. Nelen, Soetkin Leys, Jan Willem Bek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
I.H. Nelen, Soetkin Leys, Jan Willem Bek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
TGF-β Promotes Hepatocellular Carcinoma Metastasis Through Through m6A Modification of PCDHGA9
H Wang, Wen Guan, Xianzhou Zhang, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024) Vol. 39, Iss. 9, pp. 644-653
Closed Access | Times Cited: 1
H Wang, Wen Guan, Xianzhou Zhang, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024) Vol. 39, Iss. 9, pp. 644-653
Closed Access | Times Cited: 1
Interpretable deep cross networks unveiled common signatures of dysregulated epitranscriptomes across 12 cancer types
Rong Xia, Xiangyu Yin, Jiaming Huang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102376-102376
Open Access | Times Cited: 1
Rong Xia, Xiangyu Yin, Jiaming Huang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102376-102376
Open Access | Times Cited: 1
Exploring the Biological Role of METTL3 in Kummell’s Disease
Akerman Ke
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 82-87
Closed Access
Akerman Ke
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 82-87
Closed Access
Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer
Rachel Shoemaker, Mo-Fan Huang, Ying-Si Wu, et al.
NAR Cancer (2024) Vol. 6, Iss. 3
Open Access
Rachel Shoemaker, Mo-Fan Huang, Ying-Si Wu, et al.
NAR Cancer (2024) Vol. 6, Iss. 3
Open Access
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells
Xiaoping Zheng, Huiying Li, Jian Lin, et al.
Journal of Chemotherapy (2024), pp. 1-11
Closed Access
Xiaoping Zheng, Huiying Li, Jian Lin, et al.
Journal of Chemotherapy (2024), pp. 1-11
Closed Access
